Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
CorrectionJournal of the American College of Cardiology, 2017-02, Vol.69 (5), p.601 [Peer Reviewed Journal]Copyright Elsevier Limited Feb 7, 2017 ;ISSN: 0735-1097 ;EISSN: 1558-3597 ;DOI: 10.1016/j.jacc.2016.12.008Full text available |
|
2 |
Material Type: Article
|
No money for new drugsNature (London), 2020-10, Vol.586 (7830), p.S50-S52 [Peer Reviewed Journal]Copyright Nature Publishing Group Oct 22, 2020 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/d41586-020-02884-3Full text available |
|
3 |
Material Type: Article
|
Pharmaceutical Quality by Design: Product and Process Development, Understanding, and ControlPharmaceutical research, 2008-04, Vol.25 (4), p.781-791 [Peer Reviewed Journal]US Government: Food and Drug Administration 2007 ;2008 INIST-CNRS ;Springer Science+Business Media, LLC 2008 ;ISSN: 0724-8741 ;EISSN: 1573-904X ;DOI: 10.1007/s11095-007-9511-1 ;PMID: 18185986 ;CODEN: PHREEBFull text available |
|
4 |
Material Type: Article
|
Cabozantinib versus everolimus in advanced renal cell carcinoma (METEOR): final results from a randomised, open-label, phase 3 trialThe lancet oncology, 2016-07, Vol.17 (7), p.917-927 [Peer Reviewed Journal]Elsevier Ltd ;2016 Elsevier Ltd ;Copyright © 2016 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Jul 01, 2016 ;ISSN: 1470-2045 ;EISSN: 1474-5488 ;DOI: 10.1016/S1470-2045(16)30107-3 ;PMID: 27279544 ;CODEN: LANCAOFull text available |
|
5 |
Material Type: Article
|
Opioid Crisis: No Easy Fix to Its Social and Economic DeterminantsAmerican journal of public health (1971), 2018-02, Vol.108 (2), p.182-186 [Peer Reviewed Journal]Copyright American Public Health Association Feb 2018 ;American Public Health Association 2018 2018 ;ISSN: 0090-0036 ;EISSN: 1541-0048 ;DOI: 10.2105/AJPH.2017.304187 ;PMID: 29267060Full text available |
|
6 |
Material Type: Article
|
Responding to the opioid crisis in North America and beyond: recommendations of the Stanford–Lancet CommissionThe Lancet (British edition), 2022-02, Vol.399 (10324), p.555-604 [Peer Reviewed Journal]2022 Elsevier Ltd ;2022. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(21)02252-2 ;PMID: 35122753Full text available |
|
7 |
Material Type: Article
|
Trends in Opioid Analgesic Abuse and Mortality in the United StatesThe New England journal of medicine, 2015-01, Vol.372 (3), p.241-248 [Peer Reviewed Journal]Copyright © 2015 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMsa1406143 ;PMID: 25587948Full text available |
|
8 |
Material Type: Article
|
WHAT HAPPENED TO THE 'GAME CHANGING' COVID DRUG PAXLOVID?Nature (London), 2023-01, Vol.613 (7943), p.224-225 [Peer Reviewed Journal]Copyright Nature Publishing Group Jan 12, 2023 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/d41586-022-04576-6Full text available |
|
9 |
Material Type: Article
|
Sex differences in pharmacokinetics predict adverse drug reactions in womenBiology of sex differences, 2020-06, Vol.11 (1), p.32-14, Article 32 [Peer Reviewed Journal]COPYRIGHT 2020 BioMed Central Ltd. ;COPYRIGHT 2020 BioMed Central Ltd. ;2020. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2020 ;ISSN: 2042-6410 ;EISSN: 2042-6410 ;DOI: 10.1186/s13293-020-00308-5 ;PMID: 32503637Full text available |
|
10 |
Material Type: Article
|
How Good Intentions Contributed to Bad Outcomes: The Opioid CrisisMayo Clinic proceedings, 2018-03, Vol.93 (3), p.344-350 [Peer Reviewed Journal]2017 Mayo Foundation for Medical Education and Research ;Copyright © 2017 Mayo Foundation for Medical Education and Research. Published by Elsevier Inc. All rights reserved. ;COPYRIGHT 2018 Frontline Medical Communications Inc. ;COPYRIGHT 2018 Elsevier, Inc. ;Copyright Mayo Foundation for Medical Education and Research Mar 2018 ;ISSN: 0025-6196 ;EISSN: 1942-5546 ;DOI: 10.1016/j.mayocp.2017.12.020 ;PMID: 29502564Full text available |
|
11 |
Material Type: Article
|
The natural history of an epidemicNature (London), 2019-09, Vol.573 (7773), p.S10-S12 [Peer Reviewed Journal]Copyright Nature Publishing Group Sep 12, 2019 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/d41586-019-02686-2Full text available |
|
12 |
Material Type: Article
|
Cardiovascular Outcomes Trials in Type 2 Diabetes: Where Do We Go From Here? Reflections From a Diabetes Care Editors' Expert ForumDiabetes care, 2018-01, Vol.41 (1), p.14-31 [Peer Reviewed Journal]2017 by the American Diabetes Association. ;Copyright American Diabetes Association Jan 1, 2018 ;2017 by the American Diabetes Association. 2017 ;ISSN: 0149-5992 ;EISSN: 1935-5548 ;DOI: 10.2337/dci17-0057 ;PMID: 29263194Full text available |
|
13 |
Material Type: Article
|
New Perspectives on How to Discover Drugs from Herbal Medicines: CAM's Outstanding Contribution to Modern TherapeuticsEvidence-based complementary and alternative medicine, 2013-01, Vol.2013, p.627375-25 [Peer Reviewed Journal]Copyright © 2013 Si-Yuan Pan et al. ;Copyright © 2013 Si-Yuan Pan et al. This is an open access article distributed under the Creative Commons Attribution License (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. https://creativecommons.org/licenses/by/4.0 ;Copyright © 2013 Si-Yuan Pan et al. 2013 ;ISSN: 1741-427X ;EISSN: 1741-4288 ;DOI: 10.1155/2013/627375 ;PMID: 23634172Full text available |
|
14 |
Material Type: Book
|
The illusive trade-off: intellectual property rights, innovation systems, and Egypt's pharmaceutical industryThe illusive trade-off, 2006, Vol.27, p.xii-xii2006 University of Toronto Press Incorporated ;ISBN: 1442681489 ;ISBN: 9781442681484 ;ISBN: 0802091806 ;ISBN: 9780802091802 ;EISBN: 1442681489 ;EISBN: 9781442681484 ;DOI: 10.3138/9781442681484 ;OCLC: 752277501 ;OCLC: 923070280 ;OCLC: 654415376 ;LCCallNum: HD9673.E3 A33 2006ebDigital Resources/Online E-Resources |
|
15 |
Material Type: Article
|
NHS England drive sees almost half a million people started on anticoagulant drugsBMJ (Online), 2023-11, Vol.383, p.p2567-2567 [Peer Reviewed Journal]Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go tohttp://group.bmj.com/group/rights-licensing/permissions2023BMJ ;ISSN: 1756-1833 ;EISSN: 1756-1833 ;DOI: 10.1136/bmj.p2567Full text available |
|
16 |
Material Type: Article
|
The global preventable cost of cancer drug wastageThe lancet oncology, 2023-09, Vol.24 (9), p.956-956 [Peer Reviewed Journal]2023 Elsevier Ltd ;2023. Elsevier Ltd ;ISSN: 1470-2045 ;EISSN: 1474-5488 ;DOI: 10.1016/S1470-2045(23)00381-9 ;PMID: 37517409Full text available |
|
17 |
Material Type: Article
|
The $2.6 Billion Pill — Methodologic and Policy ConsiderationsThe New England journal of medicine, 2015-05, Vol.372 (20), p.1877-1879 [Peer Reviewed Journal]Copyright © 2015 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMp1500848 ;PMID: 25970049Full text available |
|
18 |
Material Type: Article
|
Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trialGut, 2012-12, Vol.61 (12), p.1693-1700 [Peer Reviewed Journal]Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions ;2015 INIST-CNRS ;Copyright: 2012 Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions ;ISSN: 0017-5749 ;EISSN: 1468-3288 ;DOI: 10.1136/gutjnl-2011-301668 ;PMID: 22595313 ;CODEN: GUTTAKFull text available |
|
19 |
Material Type: Article
|
Doctors in India raise concerns about new mandate to prescribe generically or risk suspensionBMJ (Online), 2023-08, Vol.382, p.p1930-1930 [Peer Reviewed Journal]Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go tohttp://group.bmj.com/group/rights-licensing/permissions2023BMJ ;ISSN: 1756-1833 ;EISSN: 1756-1833 ;DOI: 10.1136/bmj.p1930Full text available |
|
20 |
Material Type: Article
|
Drug Companies’ Liability for the Opioid EpidemicThe New England journal of medicine, 2017-12, Vol.377 (24), p.2301-2305 [Peer Reviewed Journal]Copyright © 2017 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMp1710756 ;PMID: 29236640Full text available |